Cardinal Health Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
96 / 178
Position in country
3391 / 14179
Return on Assets, %
1.4
2.4
Net income margin, %
0.6
1.5
EBITDA margin, %
1.1
4.6
Intangible assets and goodwill, %
11.5
1.8
Revenue CAGR 3Y, %
10.2
8.3
Total Equity change 1Y, %
55.8
0
Revenue Y, % chg
11.9
1.5
P/E
41.3
17.4
P/BV
-7.5
1.2
P/S
0.1
0.6
EV/S
0.1
0.8
EV/EBITDA
9.4
8.6
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
10.8
20.7
Forward P/E
13.4
13.1
Dividend Yield, %
1.9
2.7
Forward Dividend Yield, %
1.9
0.5
Expected dividend per share
2
0.1
Payout Ratio, %
78.8
30.7
Dividend Ex Date
2024-03-28
Competitors
Ranks
-
Jointown Pharmaceutical Group Co Ltd
00%
-
Cencora Inc
00%
-
Cardinal Health Inc
00%
-
Mckesson Corp
00%
-
Owens & Minor Inc
00%
-
Adapthealth Corp
00%
-
Patterson Companies Inc
00%
-
Henry Schein Inc
00%
-
Celltrion Healthcare Co Ltd
00%
-
Covetrus Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Providers & Services
Sub-sector
Health Care
Capitalization (millions of $)
25563.8
Ticker
CAH.N
ISIN
US14149Y1082
IPO date
1983-08-04
Availability on Russian exchanges
Yes
Reporting for
2024-02-01
Date fact. publication of reports
2023-12-31
Company Description
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: